The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N alpha-(2-naphthyl-sulfonyl-glycyl)-D,L-(p-amidinophenylalanyl-piperidine) ID: ALA1077921
Cas Number: 86845-59-2
PubChem CID: 3070748
Max Phase: Preclinical
Molecular Formula: C27H31N5O4S
Molecular Weight: 521.64
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)c1ccc(C[C@H](NC(=O)CNS(=O)(=O)c2ccc3ccccc3c2)C(=O)N2CCCCC2)cc1
Standard InChI: InChI=1S/C27H31N5O4S/c28-26(29)21-10-8-19(9-11-21)16-24(27(34)32-14-4-1-5-15-32)31-25(33)18-30-37(35,36)23-13-12-20-6-2-3-7-22(20)17-23/h2-3,6-13,17,24,30H,1,4-5,14-16,18H2,(H3,28,29)(H,31,33)/t24-/m0/s1
Standard InChI Key: XXTWZTPVNIYSJZ-DEOSSOPVSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
17.8691 -15.2396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1533 -14.8271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1533 -14.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8691 -13.5896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5808 -14.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5808 -14.8271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8691 -16.0646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4416 -16.0646 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1533 -16.4771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1533 -17.3021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8691 -17.7146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5808 -17.3021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2967 -17.7146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2967 -18.5396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5808 -18.9521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8691 -18.5396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5808 -16.4771 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0126 -18.9521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7284 -18.5396 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0126 -19.7771 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.7257 -16.4771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2940 -16.4771 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0098 -16.0646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7257 -17.3021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2910 -17.3030 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.5806 -18.5437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5777 -17.7175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8635 -17.3093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1501 -17.7238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1510 -18.5464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4376 -18.9608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4406 -19.7870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1569 -20.1988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8702 -19.7843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8673 -18.9581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5000 -18.0958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.0000 -16.8833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
9 8 1 6
7 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
7 17 2 0
18 19 1 0
18 20 2 0
14 18 1 0
1 7 1 0
22 23 1 0
21 23 1 0
21 24 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
26 35 2 0
30 35 1 0
25 27 1 0
22 25 1 0
8 21 1 0
25 36 2 0
1 2 1 0
25 37 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 521.64Molecular Weight (Monoisotopic): 521.2097AlogP: 2.14#Rotatable Bonds: 9Polar Surface Area: 145.45Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.03CX Basic pKa: 11.43CX LogP: 1.41CX LogD: -0.49Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.25Np Likeness Score: -1.05
References 1. Thalassitis A, Hadjipavlou-Litina DJ, Litinas KE, Miltiadou P.. (2009) Synthesis of modified homo-N-nucleosides from the reactions of mesityl nitrile oxide with 9-allylpurines and their influence on lipid peroxidation and thrombin inhibition., 19 (22): [PMID:19811914 ] [10.1016/j.bmcl.2009.09.040 ]